Dark

ABBV
ABBVIE INC.
stock NYSE

At Close

Sep 4, 2026 3:59:59 PM EDT

256.35USD-1.485%(-3.86)4,729,801

0.00Bid 0.00Ask 0.00Spread

Pre-market

Sep 4, 2026 9:29:30 AM EDT

257.55USD-1.022%(-2.66)1,729

After-hours

Sep 4, 2026 4:23:30 PM EDT

256.50USD+0.060%(+0.15)1,382,248

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

453.02B

CEO

Richard Gonzalez

Headquarters

North Chicago, Illinois, USA

Industry

Drug Manufacturers-General

Last Dividend

Apr 15, 20251.640

AMGN NBIX GILD BIIB AZN GSK BMY LLY PFE XLV

ABBV Stats

Avg. Vol. 10 Day

3,887,025

Avg. Vol. 30 Day

4,916,645

Employees

30,000

Market Cap

453,018,187,183

Shares Out.

1,767,117,285

On/Off Exchange

55%/45%

6 Month Beta

-0.18

1 Year Beta

-0.09

2 Year Beta

0.26

3 Year Beta

0.27

52 Week Low

190.75

52 Week High

267.47

SMA50

254.48

SMA200

228.34

1 Week

-0.02%

1 Month

+5.12%

3 Month

+12.82%

6 Month

+11.41%

1 Year

+20.61%

2 Year

+32.55%

5 Year

+135.13%

Profile

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.

ABBV Stock Summary

ABBVIE INC. (NYSE:ABBV) stock price today is $256.35, and today's volume is 4,729,801. ABBV is down -1.485% today. The 30 day average volume is 4,916,645. ABBV market cap is 453.02B with 1,767,117,285 shares outstanding.

document.getElementById("r8GTnP").onerror = function(){this.style.display='none';}; .dark-mode .dspRPl{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .dspRPl{ color: #333333; background-color: white; border: 2px solid #333333; }ABBVABBVIE INC.stock NYSE

ABBV Stock Summary

ABBV
ABBVIE INC.
stock NYSE